Anshika Jain
Modern medicine has achieved remarkable success at diagnosing diseases, treating acute conditions and extending survival. Yet much of healthcare still operates around a familiar sequence: symptoms appear, a patient seeks medical attention, diagnostic tests identify a condition, and treatment begins. This model is essential for managing illness, but it can become less effective when biological changes begin years before symptoms become clinically visible.
A growing body of research is therefore pointing toward a different model of preventive medicine. Instead of viewing health as a static condition that is periodically checked, researchers are increasingly exploring health as a continuously changing trajectory that can potentially be measured, modelled and influenced over time. Advances in artificial intelligence, electronic health records, wearable sensors, genomics, multi-omics, digital biomarkers and computational modelling are making it possible to study changes in an individual’s health before they develop into obvious disease.
A 2026 conceptual framework published in BMJ Health & Care Informatics argues that artificial intelligence and increasingly multimodal biomedical datasets could support a preventive approach capable of identifying actionable changes in health before symptoms appear. The framework describes a shift from using AI primarily for diagnosis and disease management toward predicting future health changes and supporting earlier intervention.
This does not mean replacing physicians with algorithms or attempting to predict every disease with certainty. Rather, it represents a change in the fundamental question healthcare asks. Instead of asking only, “What disease does this person have?” preventive medicine may increasingly ask, “How is this person’s health changing, what factors are influencing that trajectory, and where might intervention make a meaningful difference?”
From Disease Treatment to Health Trajectories
Traditional medicine often categorises health and disease into relatively distinct states. A person may be considered healthy until a clinical threshold is crossed, after which a diagnosis becomes appropriate. However, biological processes rarely follow such clear boundaries.
Many chronic diseases develop gradually. Metabolic dysfunction, vascular changes, tissue damage, immune alterations and other biological processes can accumulate long before a person experiences significant symptoms. A diagnosis may therefore represent the point at which an underlying process becomes sufficiently measurable or clinically important rather than the precise moment when the disease began.
The emerging trajectory-based perspective attempts to capture this continuum. Instead of examining a patient’s health only at isolated appointments, it considers how measurements change across months or years. A blood-pressure pattern, metabolic marker, activity level, sleep pattern, medication history or physiological signal may become more informative when its direction and rate of change are considered alongside the individual’s previous measurements.
This distinction is important because a single measurement can be difficult to interpret. A value that appears normal according to a population reference range may represent a meaningful change for a particular individual. Conversely, an unusual measurement may not necessarily indicate disease if it is stable and appropriate for that person’s broader physiological context.
A 2026 perspective on context-aware monitoring argues that serial and multimodal measurements can help shift attention from population norms toward within-person changes, potentially improving interpretation while reducing some of the false positives that can arise from extensive screening of asymptomatic populations.
The Individual Health Baseline
For predictive prevention to work effectively, healthcare needs a better understanding of what is normal for each individual.
Population-based reference ranges remain extremely useful in medicine, but they do not capture every aspect of individual biological variation. Two people of the same age may have different resting heart rates, metabolic profiles, activity patterns, sleep characteristics and responses to stress while both remain healthy.
Longitudinal health data create the possibility of establishing an individual’s personal baseline. Instead of asking only whether a measurement falls outside a general reference interval, a predictive system could examine whether that measurement is changing unusually for that specific person.
This approach could be particularly useful when signals are subtle. A gradual change may not cross a conventional clinical threshold but could nevertheless become meaningful when considered alongside other changes. The challenge is determining which changes represent normal fluctuation and which indicate a developing health problem.
Recent research demonstrates why this distinction matters. A 2026 study in npj Digital Medicine examined high-density wearable data and found that within-person changes in heart rate, heart-rate variability and respiratory rate were associated with subsequent changes in symptoms in people with complex chronic illness. The research illustrates how repeated measurements can provide information that a single clinical observation may not capture.
The Emergence of Continuous Health Monitoring
Wearable devices and connected technologies have expanded the amount of physiological information that can potentially be collected outside clinical environments.
Smartwatches, fitness trackers, smartphones and other sensors can generate repeated measurements related to movement, heart rate, sleep, activity, temperature and other physiological or behavioural signals. Unlike traditional medical appointments, which provide snapshots, these technologies can potentially provide longitudinal observations.
The significance of continuous monitoring is not simply the volume of data. Its value depends on whether measurements can be interpreted within context and linked to meaningful clinical outcomes.
Researchers are beginning to develop new analytical frameworks for these high-dimensional sensor datasets. A 2026 npj Digital Medicine perspective introduced the concept of “sensor-wide association studies,” adapting ideas from genomics to systematically investigate large numbers of sensor-derived features in relation to clinical phenotypes.
This creates an opportunity to discover physiological patterns that may otherwise remain invisible. At the same time, it introduces a major challenge: collecting more data does not automatically produce better healthcare. Without appropriate validation and interpretation, continuous monitoring can generate noise, unnecessary concern and false alarms.
Artificial Intelligence as a Trajectory-Modelling Engine
Artificial intelligence becomes particularly relevant when healthcare moves from static measurements toward trajectories.
A patient’s longitudinal medical record can contain diagnoses, laboratory tests, medications, procedures, imaging results, clinical notes and outcomes accumulated over many years. When genomic information, wearable data or other sources are added, the resulting dataset becomes even more complex.
Traditional analytical methods can struggle with such high-dimensional, irregularly timed information. Modern machine-learning systems are increasingly capable of modelling complex relationships across multiple data types and time periods.
A 2026 Nature Reviews Genetics review describes how AI-based integration of genomic information with electronic health records is creating opportunities to study disease heterogeneity, identify biomarkers and predict disease risk. It also highlights the ability of newer machine-learning approaches to work with high-dimensional, noisy and irregularly timed healthcare data.
This could allow predictive medicine to move beyond broad population-level risk estimates toward more individualised trajectory modelling. Instead of simply estimating whether a person has a particular risk factor, a model could potentially examine how multiple factors interact and how that person’s risk is changing over time.
From Risk Scores to Dynamic Health Models
Risk scores are already widely used in healthcare. They can estimate the probability of certain outcomes using variables such as age, laboratory measurements, medical history and lifestyle factors.
Trajectory modelling represents a potential extension of this concept. Rather than producing a single risk estimate, a dynamic system could update its interpretation as new information becomes available.
Imagine a model that receives periodic laboratory measurements, medication changes, activity data and other clinically relevant observations. The objective would not necessarily be to announce that a person will develop a particular disease. Instead, the system could identify a changing pattern that warrants closer clinical evaluation.
This distinction is important because prediction is not the same as diagnosis. A predictive model may identify a statistical pattern associated with future disease without explaining why the pattern exists. Clinical evaluation remains necessary to determine whether the signal is meaningful and what action should follow.
A 2026 article in Nature Biotechnology described AI systems capable of using clinical records and health data to forecast numerous diseases years before they occur, illustrating the expanding technical potential of disease prediction. At the same time, the article frames this development as part of an emerging preventive-medicine landscape rather than as a replacement for conventional clinical care.
Multimodal Medicine and the Complete Health Picture
Individual health trajectories cannot be understood through one data type alone.
Genomic information can reveal inherited predispositions. Blood tests can describe metabolic and physiological states. Imaging can show structural changes. Electronic health records provide clinical history. Wearable sensors provide repeated physiological measurements. Lifestyle information can describe sleep, activity and behavioural patterns. Environmental information can add another layer of context.
The future of preventive medicine therefore depends partly on integrating these different forms of information.
This is where multimodal AI becomes important. A model that can analyse several forms of data simultaneously may be able to identify relationships that remain hidden when each dataset is analysed independently.
Recent research into preventive and precision medicine describes AI as a potential component of a broader “6P” framework involving predictive, preventive, personalised, participatory, precision and public-health approaches. The review also discusses the potential role of machine learning, deep learning, large language models and digital twins across these dimensions.
The objective is not simply to create a larger medical database. It is to create a more context-sensitive understanding of how multiple biological and behavioural variables interact over time.
The Digital Twin of an Individual
One of the more ambitious concepts emerging from predictive healthcare is the human digital twin.
A digital twin is a computational representation designed to reflect aspects of a real-world system. In healthcare, researchers are exploring whether an individual’s biological and clinical information could be represented through dynamic computational models capable of simulating aspects of health and disease.
Recent reviews describe human digital twins as a potential component of personalised and predictive healthcare, using real-time data, computational modelling and AI to explore physiological behaviour, treatment responses and disease trajectories.
The idea remains technologically and clinically challenging. Human biology is considerably more complicated than an engineered machine, and a computational model cannot perfectly reproduce every biological process.
Nevertheless, the digital-twin concept illustrates where trajectory-based medicine could eventually move. Instead of maintaining a static patient record, healthcare could potentially develop a dynamic computational representation that evolves as new measurements arrive.
Such systems could theoretically allow clinicians to explore possible scenarios, compare potential interventions and identify changing risk patterns. However, this remains an emerging research area rather than an established standard of clinical care.
Prevention Before the Disease Threshold
The most important implication of trajectory modelling is the possibility of identifying opportunities for intervention before conventional disease thresholds are reached.
Prevention already exists in medicine through vaccination, screening, lifestyle interventions, risk-factor management and other strategies. The emerging paradigm seeks to make prevention more personalised and dynamically timed.
If a health trajectory begins changing, the appropriate response might not necessarily be medication. Depending on the situation, the response could involve additional testing, lifestyle modification, environmental changes, closer monitoring or consultation with a healthcare professional.
This creates a more nuanced concept of preventive medicine. Prevention becomes less about predicting a predetermined future and more about identifying modifiable factors while there is still an opportunity to influence the trajectory.
A 2026 review on early detection of wellness-to-disease transitions describes the convergence of systems biology, multi-omics and AI as contributing to a shift from static biomarkers toward dynamic, systems-level approaches for early detection and personalised intervention.
Precision Prevention Across the Life Course
Preventive medicine also needs to account for the fact that health trajectories begin long before adulthood.
Genetic factors, childhood development, nutrition, physical activity, socioeconomic conditions, environmental exposures and psychosocial experiences can influence health across the life course. Some periods may be particularly sensitive to these influences.
The World Health Organization’s life-course framework emphasises that health and well-being result from interacting protective and risk factors across different stages of life and that cumulative exposures and critical periods can shape health trajectories.
This perspective complements computational health modelling. A truly individualised health trajectory cannot be based exclusively on data collected after a person becomes a patient. Understanding long-term health may require considering earlier exposures and developmental stages.
The result could be a broader definition of prevention that begins before conventional clinical risk becomes obvious.
The Difference Between Prediction and Prevention
One of the most important distinctions in this emerging field is that prediction alone does not improve health.
A highly accurate model is useful only if its predictions can be interpreted, clinically validated and connected to effective interventions. If a system predicts increased risk but there is no practical action that can reduce that risk, the value of prediction may be limited.
This is why preventive medicine needs to connect three stages: measurement, interpretation and intervention.
Measurement generates observations. Computational models identify patterns and estimate possible trajectories. Clinical and public-health systems then determine whether an intervention is appropriate.
The 2026 BMJ framework emphasises that computational systems require real-world clinical validation and careful consideration of how preventive interventions are implemented.
This prevents predictive healthcare from becoming an exercise in producing increasingly sophisticated risk scores without improving patient outcomes.
The Challenge of False Positives and Overdiagnosis
More sensitive monitoring also creates a paradox. If healthcare measures enough variables frequently enough, some abnormal-looking patterns will inevitably appear.
This is particularly important in people who have no symptoms. A predictive system may detect a statistical deviation that never develops into meaningful disease. If every deviation triggers further testing, patients may experience anxiety, unnecessary procedures and additional healthcare costs.
The challenge is therefore not simply to maximise prediction. It is to determine which signals are clinically meaningful.
The 2026 npj Digital Medicine discussion of context-aware monitoring highlights this issue and argues that repeated, multimodal measurements interpreted in context can help reduce false-positive problems compared with isolated measurements.
A mature preventive system should therefore distinguish between biological variation, temporary disruption and sustained trajectory change.
Measurement Quality May Matter More Than Model Complexity
Another important lesson emerging from recent research is that sophisticated AI cannot compensate for poor-quality data.
A 2026 npj Digital Medicine study examining individual cognitive trajectories in Parkinson’s disease found evidence that measurement fidelity, rather than model complexity, constrained predictive performance. The researchers evaluated multiple machine-learning approaches across two independent cohorts and highlighted the importance of reliable measurements when predicting individual trajectories.
This has broad implications for preventive medicine. Healthcare organisations may be tempted to focus on increasingly complex algorithms, but the quality, consistency and clinical relevance of the underlying data may matter just as much.
A smaller set of reliable measurements collected consistently over time may be more useful than enormous quantities of noisy or poorly contextualised information.
Privacy, Equity and Patient Autonomy
A trajectory-based health system would potentially collect substantially more information about individuals than conventional healthcare. This could include medical records, genomic data, wearable measurements, behavioural information, environmental exposure data and other longitudinal signals.
Such information is deeply personal. Strong privacy protections, transparent data governance and meaningful patient consent would therefore be essential.
Equity is another major consideration. Predictive models trained primarily on particular populations may perform differently in populations that are underrepresented in the underlying data. Access to wearable technology, regular healthcare, genetic testing and digital monitoring may also vary across socioeconomic groups.
The World Health Organization’s 2026 resolution on precision medicine explicitly connects precision approaches with ethical, legal and equity considerations, recognising that the use of clinical, molecular, genomic and other health data must occur within appropriate safeguards.
Preventive medicine should therefore become more personalised without becoming less equitable.
The Future of Healthcare May Be Trajectory-Aware
The emerging preventive medicine paradigm does not eliminate traditional diagnosis. Doctors will continue to diagnose diseases, treat acute illness, manage chronic conditions and respond to symptoms.
What changes is the layer that surrounds these activities.
Healthcare could increasingly become trajectory-aware, using longitudinal information to understand whether an individual’s biological state is stable, improving, deteriorating or undergoing an unusual transition. Clinical encounters could then be informed by a richer picture of what has happened between appointments.
This could eventually change the role of the medical check-up. Instead of functioning primarily as an isolated assessment, a check-up could become one point within a continuous longitudinal health model.
The goal would be to identify meaningful changes early enough that intervention can influence the trajectory rather than simply responding after disease has become established.
Conclusion
The preventive medicine paradigm is gradually moving from a model centred on disease detection toward a model increasingly interested in the evolution of individual health over time. Advances in AI, multi-omics, electronic health records, wearable sensors, digital biomarkers and computational modelling are creating the technical foundations for this transition.
The central idea is not that medicine should predict the future with certainty. Human biology is too complex for that. Instead, the objective is to understand health as a changing trajectory and identify meaningful deviations early enough to create opportunities for prevention.
This requires moving beyond isolated measurements toward longitudinal context, beyond population averages toward individual baselines, and beyond disease labels toward continuous biological states. It also requires recognising the limits of prediction, validating models in real clinical environments, protecting patient privacy and ensuring that technological progress remains connected to meaningful interventions.
The future of preventive medicine may therefore be less about waiting for disease to announce itself and more about understanding the gradual biological processes that precede it. By combining longitudinal health information with systems biology and responsible AI, healthcare could increasingly become capable of asking not only what is happening to a person today, but how that person’s health is changing, why it may be changing, and where intervention could potentially alter the trajectory.